These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15380602)

  • 21. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.
    Nasser NJ; Cohen GN; Dauer LT; Zelefsky MJ
    Brachytherapy; 2016; 15(4):420-425. PubMed ID: 27180125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):81-8. PubMed ID: 14697424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy.
    Hanania AN; Kudchadker RJ; Bruno TL; Tang C; Anscher MS; Frank SJ
    Brachytherapy; 2020; 19(1):38-42. PubMed ID: 31812590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapy.
    Herstein A; Wallner K; Merrick G; Orio P; Thornton K; Butler W; Sutlief S
    Am J Clin Oncol; 2008 Feb; 31(1):6-10. PubMed ID: 18376221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
    Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection.
    Peddada AV; Jennings SB; Faricy PO; Walsh RA; White GA; Monroe AT
    J Urol; 2007 Nov; 178(5):1963-7. PubMed ID: 17868718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
    Niehaus A; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):136-43. PubMed ID: 16198062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1056-62. PubMed ID: 15001245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
    Acher PL; Popert R; Morris SL; Potters L; Austin-Smith SL; Johnson UH; Nichol JE; Beaney RP
    BJU Int; 2007 May; 99(5):1066-71. PubMed ID: 17233801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Donzella JG
    Urology; 2001 Mar; 57(3):524-9. PubMed ID: 11248632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
    Crook J; McLean M; Yeung I; Williams T; Lockwood G
    Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy.
    Potters L; Wang XH; Yamada Y
    Tech Urol; 2000 Jun; 6(2):99-103. PubMed ID: 10798808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD; Thames HD; Kuban DA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation.
    Stone NN; Ratnow ER; Stock RG
    Tech Urol; 2000 Jun; 6(2):123-7. PubMed ID: 10798813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
    Potters L; Calugaru E; Jassal A; Presser J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant.
    Stock RG; Stone NN; Lo YC
    Tech Urol; 2000 Jun; 6(2):95-8. PubMed ID: 10798807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Allen Z; Adamovich E
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):32-43. PubMed ID: 15629591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.